UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognosis and improved outcomes in major depression: a review

Translational psychiatry, 2019-04, Vol.9 (1), p.127-127, Article 127

2019

Volltextzugriff (PDF)

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Nature (London), 2016-05, Vol.533 (7604), p.481-486

2016

Volltextzugriff (PDF)

The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis

Bipolar disorders, 2009-06, Vol.11 (s2), p.92-109

2009

Volltextzugriff (PDF)

Histone Deacetylases and Mood Disorders: Epigenetic Programming in Gene‐Environment Interactions

CNS neuroscience & therapeutics, 2011-12, Vol.17 (6), p.699-704

2011

Volltextzugriff (PDF)

Novel Insights into Lithium’s Mechanism of Action: Neurotrophic and Neuroprotective Effects

Neuropsychobiology, 2010-01, Vol.62 (1), p.50-60

2010

Volltextzugriff (PDF)

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects

EJNMMI research, 2018-07, Vol.8 (1), p.57-9, Article 57

2018

Volltextzugriff (PDF)

Ketamine for Treatment-Resistant Depression: The First Decade of Progress

1, 2016

Volltextzugriff (PDF)

Ketamine: a new chapter in antidepressant development

Revista brasileira de psiquiatria, 2020-11, Vol.42 (6), p.581-582

Zarate, Jr, Carlos A

2020

Volltextzugriff (PDF)

New targets for rapid antidepressant action

Progress in neurobiology, 2017-05, Vol.152, p.21-37

2017

Volltextzugriff (PDF)

The antidepressant actions of ketamine and its enantiomers

Pharmacology & therapeutics (Oxford), 2023-06, Vol.246, p.108431-108431, Article 108431

2023

Volltextzugriff (PDF)

Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders

Current pharmaceutical design, 2009-05, Vol.15 (14), p.1595-1611

2009

Volltextzugriff (PDF)

Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects?

Molecular psychiatry, 2024-04, Vol.29 (9), p.2849-2858

2024

Volltextzugriff (PDF)

NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine

The Journal of neuroscience, 2023-02, Vol.43 (6), p.1038-1050

2023

Volltextzugriff (PDF)

Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments

The international journal of neuropsychopharmacology, 2019-02, Vol.22 (2), p.119-135

2019

Volltextzugriff (PDF)

Early improvement with lithium in classic mania and its association with later response

Journal of affective disorders, 2013-01, Vol.144 (1), p.160-164

2013

Volltextzugriff (PDF)

Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy

Second edition., 2017

Volltextzugriff (PDF)

Key considerations for clinical trials in psychopharmacology

World psychiatry, 2023-02, Vol.22 (1), p.76-77

Zarate, Carlos A.

2023

Volltextzugriff (PDF)

Pharmacodynamic properties of lumateperone and its efficacy in acute bipolar depression: a mechanistic hypothesis based on data

European neuropsychopharmacology, 2024-04, Vol.81, p.1-9

2024

Volltextzugriff (PDF)

A Developmental Study of the Neural Circuitry Mediating Motor Inhibition in Bipolar Disorder

The American journal of psychiatry, 2012-06, Vol.169 (6), p.633-641

2012

Volltextzugriff (PDF)

Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion

iScience, 2023-12, Vol.26 (12), p.108527-108527, Article 108527

2023

Volltextzugriff (PDF)

Leveraging a cross-species probabilistic reward task (PRT) in suicide research. A commentary on Luc and Kangas (2024)

Cognitive, affective, & behavioral neuroscience, 2024-04, Vol.24 (2), p.289-291

2024

Volltextzugriff (PDF)

The Dynamic Relationship Between Alpha and Beta Power and Next-Day Suicidal Ideation in Individuals With Treatment-Resistant Depression

Biological psychiatry global open science, 2022-01, Vol.2 (1), p.36-44

2022

Volltextzugriff (PDF)

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?

Neuropsychiatric disease and treatment, 2018-01, Vol.14, p.2739-2748

2018

Volltextzugriff (PDF)

A single infusion of ketamine improves depression scores in patients with anxious bipolar depression

Bipolar disorders, 2015-06, Vol.17 (4), p.438-443

2015

Volltextzugriff (PDF)

1 – 25 von 424

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(385)
Mit Volltextzugriff
(351)

Publikationsform

Artikel
(393)
Buchkapitel
(25)
Bücher
(6)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(361)
Life Sciences & Biomedicine
(352)
Humans
(303)
Psychiatry
(282)
Neurosciences & Neurology
(203)
Male
(178)
Female
(175)
Neurosciences
(173)
Adult
(166)
Depression
(147)
Ketamine
(129)
Middle Aged
(124)
Bipolar Disorder
(103)
Pharmacology & Pharmacy
(100)
Antidepressive Agents - Therapeutic Use
(95)
Depressive Disorder, Major - Drug Therapy
(90)
Bipolar Disorder - Drug Therapy
(88)
Clinical Neurology
(86)
Medical Sciences
(86)
Biological And Medical Sciences
(85)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Prognosis and improved outcomes in major depression: a review

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis

Histone Deacetylases and Mood Disorders: Epigenetic Programming in Gene‐Environment Interactions

Novel Insights into Lithium’s Mechanism of Action: Neurotrophic and Neuroprotective Effects

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects

Ketamine for Treatment-Resistant Depression: The First Decade of Progress

Ketamine: a new chapter in antidepressant development

New targets for rapid antidepressant action

The antidepressant actions of ketamine and its enantiomers

Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders

Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects?

NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine

Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments

Early improvement with lithium in classic mania and its association with later response

Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy

Key considerations for clinical trials in psychopharmacology

Pharmacodynamic properties of lumateperone and its efficacy in acute bipolar depression: a mechanistic hypothesis based on data

A Developmental Study of the Neural Circuitry Mediating Motor Inhibition in Bipolar Disorder

Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion

International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder

Leveraging a cross-species probabilistic reward task (PRT) in suicide research. A commentary on Luc and Kangas (2024)

The Dynamic Relationship Between Alpha and Beta Power and Next-Day Suicidal Ideation in Individuals With Treatment-Resistant Depression

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?

A single infusion of ketamine improves depression scores in patients with anxious bipolar depression

Suchergebnisse filtern